Cite
Sampling endoscopically normal large bowel mucosa from patients presenting with elevated faecal calprotectin levels is not clinically justified.
MLA
Wong, Newton A. C. S., et al. “Sampling Endoscopically Normal Large Bowel Mucosa from Patients Presenting with Elevated Faecal Calprotectin Levels Is Not Clinically Justified.” Journal of Clinical Pathology, vol. 75, no. 3, Mar. 2022, pp. 205–08. EBSCOhost, https://doi.org/10.1136/jclinpath-2020-207343.
APA
Wong, N. A. C. S., Wallage, M. J., Virgo, P., & Lowes, H. (2022). Sampling endoscopically normal large bowel mucosa from patients presenting with elevated faecal calprotectin levels is not clinically justified. Journal of Clinical Pathology, 75(3), 205–208. https://doi.org/10.1136/jclinpath-2020-207343
Chicago
Wong, Newton A. C. S., Michael John Wallage, Paul Virgo, and Hannah Lowes. 2022. “Sampling Endoscopically Normal Large Bowel Mucosa from Patients Presenting with Elevated Faecal Calprotectin Levels Is Not Clinically Justified.” Journal of Clinical Pathology 75 (3): 205–8. doi:10.1136/jclinpath-2020-207343.